Multifocal osteomyelitis as the first manifestation of chronic granulomatous disease;Granulomatose septique chronique révélée par une ostéomyélite multifocale

Revue de Chirurgie Orthopedique et Reparatrice de l'Appareil Moteur

Volumn 89, Issue 6, 2003, Pages 544-548

  Launay, F ^a   Sobler, J M ^a   Kone Paut, I ^b   Viehweger, E ^a   Jouve, J L ^a   Bollini, G ^a  

^a TIMONE HOSPITAL   (France)

^b HÔPITAL NORD   (France)

Author keywords

Child; Chronic granulomatous disease; Osteomyelitis

Indexed keywords

ANTIBIOTIC AGENT; COTRIMOXAZOLE;

ANTIBIOTIC PROPHYLAXIS; ARTICLE; CASE REPORT; CHEMOLUMINESCENCE; CHRONIC DISEASE; CLINICAL FEATURE; DEBRIDEMENT; DIFFERENTIAL DIAGNOSIS; GRANULOMATOSIS; HAND RADIOGRAPHY; HUMAN; MALE; OSTEOMYELITIS; PRESCHOOL CHILD; PROGNOSIS;

CONSANGUINITY; DIAGNOSIS, DIFFERENTIAL; GRANULOMATOUS DISEASE, CHRONIC; HUMANS; INFANT; MALE; OSTEOMYELITIS; TREATMENT OUTCOME;

EID: 0142027165     PISSN: 00351040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. SEGAL BH, LETO TL, GALLIN J.I., MALECH HL, HOLLAND SM: Genetic, biochemical, and clinical features of chronic granulomatous disease. Medicine (Baltimore), 2000, 79, 170-200.
2. MULLIEZ P, JAGGI F, DARRAS A, DEMORY JL, SMITH M: Pulmonary aspergillosis complicating chronic septic granulomatosis. Treatment with itraconazole and gamma interferon. Rev Mal Respir, 2000, 17, 975-978.
3. MOUY R, FISHER A, VILMER E, SEGER R, GRISCELLI C: Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr, 1989, 114, 555-560.
4. BARBOUCHE MR, SGHIRI R, MELLOUILI F, BOUKHDIR Y, DELLAGI K, BEJAOUI M: Granulomatose septique chronique, 14 observations. Presse Med, 1999, 28, 2034-2036.
5. CASIMIR C, CHETTY M, BOHLER MC, GARCIA R, FISCHER A, GRISCELLI C, et al.: Identification of the defective NADPH-oxidase component in chronic granulomatous disease: a study of 57 European families. Eur J Clin Invest, 1992, 22, 403-406.
6. MEISCHL C, ROOS D: The molecular basis of chronic granulomatous disease. Springer Semin Immunopathol, 1998, 19, 417-434.
7. BEJAOUI M, BARBOUCHE MR, SASSI A, LARGUCHE B, MILADI N, BOUGUERRA A, et al.: Les déficits immunitaires primitifs en Tunisie: étude de 152 cas. Arch Pediatr, 1997, 4, 827-837.
8. MOUY R, ROPERT JC, DONADIEU J, HUBERT P, DE BLIC J, REVILLON Y. et al.: Granulomatose septique chronique révélée par une aspergillose néonatale. Arch Pediatr, 1995, 2, 861-864.
9. LIESE JG, JENDROSSEK V, JANSSON A, PETROPOULOU T, KLOOS S, GAHR M, et al.: Chronic granulomatous disease in adults. Lancet, 1996, 347, 220-223.
10. MOUY R: Granulomatose septique chronique. Aspects cliniques et thérapeutiques. Ann Pediatr (Paris), 1989, 36, 374-378.
11. SPONSELLER PD, MALECH HL, MC CARTHY EF Jr, HOROWITZ SF, JAFFE G, GALLIN JI: Skeletal involvement in children who have chronic granulomatous disease. J Bone Joint Surg (Am), 1991, 73, 37-51.
12. MAZIGH M'RAD S, SGHAIER K, BOUKTHIR S, BARBOUCH R, BARSAOUI S: Chronic septic granulomatosis in a young girl manifesting as invasive pulmonary aspergillosis and flaccid paraplegia. Tunis Med, 2000, 78, 210-215.
13. HORWITZ ME, BARRETT AJ, BROWN MR, CARTER CS, CHILDS R, GALLIN JI, et al.: Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft. N Engl J Med, 2001, 344, 881-888.
14. GOLDBLATT D: Current treatment options for chronic granulomatous disease. Expert Opin Pharmacother, 2002, 3, 857-863.